A chemical biology approach towards a Synthetic Lethality-based Anticancer therapy through the use of RAD51/RAD52 inhibitors Acronyme: SyLAR

Project
A chemical biology approach towards a Synthetic Lethality-based Anticancer therapy through the use of RAD51/RAD52 inhibitors Acronyme: SyLAR

Overview

Contributors

MINUCCI SAVERIO   Scientific Manager  

Departments involved

Type

PRIN2022 - PRIN bando 2022

Funder

MINISTERO DELL'UNIVERSITA' E DELLA RICERCA
External Organization Funding Organization

Date/time interval

October 18, 2023 - February 28, 2026

Project duration

28 months